
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of KRAS splice variants in cancer biology
Cristina Nuevo‐Tapioles, Mark R. Philips
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 32
Cristina Nuevo‐Tapioles, Mark R. Philips
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Qinglong Ma, Wenyang Zhang, Kongming Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Qinglong Ma, Wenyang Zhang, Kongming Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer
Shahab Fatima, Vineet Kumar, Dhruv Kumar
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 2
Shahab Fatima, Vineet Kumar, Dhruv Kumar
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 2
Comparative analysis of KRAS4a and KRAS4b splice variants reveals distinctive structural and functional properties
Matthew J. Whitley, Timothy H. Tran, M A Rigby, et al.
Science Advances (2024) Vol. 10, Iss. 7
Open Access | Times Cited: 10
Matthew J. Whitley, Timothy H. Tran, M A Rigby, et al.
Science Advances (2024) Vol. 10, Iss. 7
Open Access | Times Cited: 10
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
Victor Hugo Fonseca de Jesus, Maria Cecília Mathias-Machado, João Paulo Fogacci de Farias, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5015-5015
Open Access | Times Cited: 17
Victor Hugo Fonseca de Jesus, Maria Cecília Mathias-Machado, João Paulo Fogacci de Farias, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5015-5015
Open Access | Times Cited: 17
Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review
Fernand Bteich, Mahshid Mohammadi, T. Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12030-12030
Open Access | Times Cited: 14
Fernand Bteich, Mahshid Mohammadi, T. Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12030-12030
Open Access | Times Cited: 14
Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells
Dušan Hrčkulák, Jakub Onhajzer, Michaela Krausová, et al.
Transgenic Research (2025) Vol. 34, Iss. 1
Open Access
Dušan Hrčkulák, Jakub Onhajzer, Michaela Krausová, et al.
Transgenic Research (2025) Vol. 34, Iss. 1
Open Access
Evaluation of molecular glue-induced neo-Protein-Protein Interaction with a cell lysate-based TR-FRET assay
Xiulei Mo, Yuhong Du, Haian Fu
(2025), pp. 100003-100003
Open Access
Xiulei Mo, Yuhong Du, Haian Fu
(2025), pp. 100003-100003
Open Access
The Significance of MAPK Signaling Pathway in the Diagnosis and Subtype Classification of Intervertebral Disc Degeneration
Yong Liu, Xueyan Chen, Jingwen Chen, et al.
JOR Spine (2025) Vol. 8, Iss. 1
Open Access
Yong Liu, Xueyan Chen, Jingwen Chen, et al.
JOR Spine (2025) Vol. 8, Iss. 1
Open Access
Origin and Evolution of RAS Membrane Targeting
Antonio García‐España, Mark R. Philips
Oncogene (2023) Vol. 42, Iss. 21, pp. 1741-1750
Open Access | Times Cited: 9
Antonio García‐España, Mark R. Philips
Oncogene (2023) Vol. 42, Iss. 21, pp. 1741-1750
Open Access | Times Cited: 9
An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Novel druggable space in human KRAS G13D discovered using structural bioinformatics and a P-loop targeting monoclonal antibody
Oscar Jungholm, Carolina L. Trkulja, M. Moche, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Oscar Jungholm, Carolina L. Trkulja, M. Moche, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Targeted splicing therapy: new strategies for colorectal cancer
Yifeng Zheng, Guoqiang Zhong, Chengcheng He, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Yifeng Zheng, Guoqiang Zhong, Chengcheng He, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
The Target Therapy Hyperbole: “KRAS (p.G12C)”—The Simplification of a Complex Biological Problem
Massimiliano Chetta, Anna Basile, Marina Tarsitano, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2389-2389
Open Access | Times Cited: 1
Massimiliano Chetta, Anna Basile, Marina Tarsitano, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2389-2389
Open Access | Times Cited: 1
YB-1 activating cascades as potential targets in KRAS-mutated tumors
Shayan Khozooei, Soundaram Veerappan, Mahmoud Toulany
Strahlentherapie und Onkologie (2023) Vol. 199, Iss. 12, pp. 1110-1127
Closed Access | Times Cited: 4
Shayan Khozooei, Soundaram Veerappan, Mahmoud Toulany
Strahlentherapie und Onkologie (2023) Vol. 199, Iss. 12, pp. 1110-1127
Closed Access | Times Cited: 4
Genomic alterations and diagnosis of renal cancer
Xingming Zhang, Hella Anna Bolck, Niels J. Rupp, et al.
Virchows Archiv (2023) Vol. 484, Iss. 2, pp. 323-337
Open Access | Times Cited: 4
Xingming Zhang, Hella Anna Bolck, Niels J. Rupp, et al.
Virchows Archiv (2023) Vol. 484, Iss. 2, pp. 323-337
Open Access | Times Cited: 4
Mapping alternative splicing events in colorectal cancer
Yifeng Zheng, Guoqiang Zhong, Qiuyu Song, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Yifeng Zheng, Guoqiang Zhong, Qiuyu Song, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
KRAS (Kirsten rat sarcoma) in modern oncology—The molecular pathological point of view
Katja Schmitz, Christoph Schatz, Ludwig Knabl
memo - Magazine of European Medical Oncology (2024) Vol. 17, Iss. 4, pp. 287-291
Closed Access | Times Cited: 1
Katja Schmitz, Christoph Schatz, Ludwig Knabl
memo - Magazine of European Medical Oncology (2024) Vol. 17, Iss. 4, pp. 287-291
Closed Access | Times Cited: 1
Aberrant pre-mRNA processing in cancer
Jeetayu Biswas, Leora Boussi, Eytan M. Stein, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 11
Open Access | Times Cited: 1
Jeetayu Biswas, Leora Boussi, Eytan M. Stein, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 11
Open Access | Times Cited: 1
RNA splicing alterations in lung cancer pathogenesis and therapy
Yueren Yan, Yunpeng Ren, Yufang Bao, et al.
Cancer Pathogenesis and Therapy (2023) Vol. 1, Iss. 4, pp. 272-283
Open Access | Times Cited: 3
Yueren Yan, Yunpeng Ren, Yufang Bao, et al.
Cancer Pathogenesis and Therapy (2023) Vol. 1, Iss. 4, pp. 272-283
Open Access | Times Cited: 3
Differential functions of the KRAS splice variants
Juan Andres Kochen Rossi, Cristina Nuevo‐Tapioles, Mark R. Philips
Biochemical Society Transactions (2023) Vol. 51, Iss. 3, pp. 1191-1199
Closed Access | Times Cited: 3
Juan Andres Kochen Rossi, Cristina Nuevo‐Tapioles, Mark R. Philips
Biochemical Society Transactions (2023) Vol. 51, Iss. 3, pp. 1191-1199
Closed Access | Times Cited: 3
How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors
Weronika Wojtyś, Magdalena Oroń
Cancers (2023) Vol. 15, Iss. 11, pp. 2918-2918
Open Access | Times Cited: 3
Weronika Wojtyś, Magdalena Oroń
Cancers (2023) Vol. 15, Iss. 11, pp. 2918-2918
Open Access | Times Cited: 3
Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections
Sung‐Gwon Lee, Priscilla A. Furth, Lothar Hennighausen, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109177-109177
Open Access
Sung‐Gwon Lee, Priscilla A. Furth, Lothar Hennighausen, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109177-109177
Open Access
The Many Roads from Alternative Splicing to Cancer: Molecular Mechanisms Involving Driver Genes
Francisco Gimeno-Valiente, Gerardo López‐Rodas, Josefa Castillo, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2123-2123
Open Access
Francisco Gimeno-Valiente, Gerardo López‐Rodas, Josefa Castillo, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2123-2123
Open Access
KRAS inhibitors in drug resistance and potential for combination therapy
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access